| 1 |
What is the primary function of AI in the medical imaging industry?
|
To improve diagnostic accuracy and patient outcomes |
|
By using AI, doctor can diagnose patient with advanced technology and improve accuracy, for example, sharp x-ray film, and CT scan. |
Without AI, diagnosing some symptom will almost impossible. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
Which of the following is a key benefit of AI in radiology noted in the article?
|
Acts as a second medical opinion |
|
AI can interpret medical images in order to provide second option treatment plan for patient. |
AI can interpret medical image that is more complicated which improve a clinical outcome. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
What does AI literacy refer to according to the article?
|
Understanding and knowledge of AI technology |
|
AI literacy is one of a factor that make AI become more accepted. |
In the article, by having an understand about AI makes people understand and know how beneficial is to have AI to help in daily task or work. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
Which factor is NOT listed as influencing the acceptability of AI among healthcare professionals?
|
The color of the AI machines |
|
Color of AI machine have nothing to do with making people accept AI and its ability to perform task. |
It doesn't mention in the article. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
What role does social influence play in AI acceptability in healthcare according to the article?
|
Affects healthcare professionals’ decisions to use AI |
|
Some people believe that AI are risky and not suitable for medical task, which this makes professional unsure about their decision to use AI, decrease acceptability. |
When people don't believe in AI and lose trust, professionals are not able to use AI to help with their tasks because it will cause patients to feel unsafe or uncomfortable. This leads to reduction of AI accpetability |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
What is a perceived threat regarding AI usage in healthcare settings?
|
Concerns about replacing healthcare professionals |
|
When AI becomes more advanced, it can do most of the medical tasks, therefore, there is a concern that this might lead to replacing of healthcare professionals. |
AI is much cheaper than a lot of medical professions salary, which makes there is a chance of replacing doctors and other professions with AI. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
According to the article, what is essential for increasing AI acceptability among medical professionals?
|
Designing human-centred AI systems |
|
Human centered AI is beyond high algorithmic performance AI, which this help improve workflow and increase AI acceptability. |
When human is involved in AI, it become more trusty and professional than purely relies of AI |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
What does the 'system usage' category of AI acceptability factors include according to the article?
|
Factors like value proposition and integration with workflows |
|
Usage of AI is mainly improve workflow |
Using AI can benefit medical task by reduce speed to perform a certain task and enhance quality of interpret data, |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
How does ethicality impact AI acceptability among healthcare professionals?
|
Affects views on AI based on compatibility with professional values |
|
If AI is tested and approved that it is ethical to use in medical field, it can increase AI acceptability amount healthcare professionals. |
Ethicality makes AI become more reliable and efficiency which makes professionals feels confident and sure to use. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
What methodological approach did the article emphasize for future AI acceptability studies?
|
Considering user experience and system integration deeply |
|
By considering user experience, it makes AI become more accurate and thoughtful, which would lead to increasing of AI acceptability. |
- |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
What is the primary objective of using human embryonic stem cells in treating Parkinson’s disease?
|
To replace lost dopamine neurons. |
|
human embryonic stem cell have a potential to generate pure dopamine-producing neurons which would solve the problem |
By using this dopamine producing neuron will be replaced and basically heal Parkinson Disease which dopamine producing neuron are destroyed. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
Which animal was used to test the STEM-PD product for safety and efficacy?
|
Rats |
|
Rat were use to test efficiency and safetiness of using human embryonic stem-cell to treat Parkinson disease. |
Rats is being used to carry this investigation because it very biologically similar to human and cost very little. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What was the duration of the preclinical safety study in rats mentioned in the article?
|
9 months |
|
During these 9 months, the researchers do toxicity tumorigenicity and biodistribution on a human embryonic stem cell |
This help test safety of this method before actually use it in both rats and human |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
What is the name of the clinical trial phase mentioned for STEM-PD?
|
Phase I/IIa |
|
It is a phase where researcher actually test with human |
STEM-PD is a phase after researcher already done testing with rats and confident enough to test in human |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
How is the STEM-PD product manufactured?
|
Under GMP-compliant conditions |
|
It pass quality tested invitro and invivo |
This manufactured occurs after the research already full functional recovery in pre-clinical rat model of PD |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
According to the article, what confirmed the safety of the STEM-PD product in rats?
|
There were no adverse effects or tumor formation. |
|
Adverse Effect did not occurs, which implies that it is safe. |
Tested by toxicity, adverse effect are not occurs |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
What key finding was noted in the efficacy study of STEM-PD in rats?
|
The cells could not differentiate into dopamine neurons |
|
stem cell released dopamine into the damaged striatum in vivo |
The key finding is this human embyonic stemcell actually survive and function properly to replace neuron that create dopamine. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What specific markers were used to assess the purity of the STEM-PD batch?
|
FOXA2 and OTX2 |
|
this indicator help differentiates neuron that produce dopamine from human embryonic stem cell |
Using FOXA2 and OTX2 help researcher see if they function properly |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
What role do growth factors like FGF8b and SHH play in the manufacturing process of STEM-PD?
|
They prevent differentiation. |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
What was a key outcome measured in the preclinical trials for efficacy in rats?
|
Recovery of motor function |
|
Since Parkinson disease led to disfunction of motor, using STEM-PD allows rat to gain back this ability. |
When dopamine is produced enough by human embryonic stem cell, the body is recover motor function. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|